Arex Advisor welcomes regulatory expert Alice Genevet
Basel, Switzerland 15 September 2025 Arex Advisor are happy to welcome Alice Genevet as Expert Regulatory Affairs. Alice specialises in Regulatory Affairs, mainly for Europe. She is experienced in leading cross-functional projects across the full product life cycle, with a focus on pre-MAA and MAA activities. Her regulatory expertise includes regulatory strategy and preparation of […]
EMA news highlights July-August 2025
28 August 2025 From the European Medicines Agency’s (EMA) newsfeed, Arex Advisor has rounded up a selection of highlights from July to August 2025. Clinical Trials Regulation: progress on implementation 26 August 2025A new report on the authorisation of clinical trials in the European Union (EU) and European Economic Area (EEA) has been published. A total […]
Swissmedic news highlights July-August 2025
28 August 2025 From the Swissmedic newsfeed, Arex Advisor has rounded up a selection of highlights from July to August 2025. Swissmedic warns of falsified GLP-1 weight loss products 26 August 2025Swissmedic has alerted the public to the growing circulation of falsified and unauthorised “GLP-1” weight loss products, which may contain undeclared, harmful, or incorrectly […]
MHRA news highlights July-August 2025
28 August 2025 From the newsfeeds of the Medicines and Healthcare products Regulation Agency, Arex Advisor has rounded up a selection of highlights from July to August 2025. Medicines marketing authorisation: change of ownership application 14 August 2025An updated version of the attachment for change of ownership application has been published. Read more Cancel a […]
Nordic regulatory news highlights July-August 2025
28 August 2025 From the newsfeeds of the Nordic medical product agencies, Arex Advisor has rounded up a selection of highlights from July to August 2025. SWEDEN SweTrial initiative launched to boost clinical trials in Sweden 31 July 2025The Swedish government has decided to establish the SweTrial partnership, aimed at strengthening Sweden’s position as a […]
Anja Bührer joins Arex Advisor as Swiss General Manager
Stockholm, Sweden 23 July 2025 Arex Advisor are happy to welcome Anja Bührer as General Manager and Vice President Regulatory Affairs for Arex Advisor AG, the Swiss entity of the Arex Advisor group. With over 12 years of experience in leadership and Regulatory Affairs, Anja has extensive hands-on experience leading regulatory and cross-functional activities from […]
Arex Advisor strengthens Market Access offering with Swiss expertise
Stockholm, Sweden 1 July 2025 Arex Advisor is pleased to welcome Marietta Hartl, Senior Market Access Consultant, to the team. With this strategic move, Arex Advisor reinforces the commitment to delivering tailored Market Access services across Europe. Marietta brings valuable experience in delivering comprehensive pricing and reimbursement submissions, engagement with regional payers, integration with broader […]
Annual report 2024 Arex Advisor AB
Read the annual report here
Arex Advisor welcomes Delphine Guérin as new Business Development Director
Stockholm, Sweden 2 May 2025 Arex Advisor is delighted to announce the recruitment of Delphine Guérin as our new Business Development Director. Delphine brings a strong track record of driving commercial growth and supporting innovation, with proven expertise in building long term client relationships and navigating complex projects. She holds a PhD in Neuroscience from […]
9 things to consider before starting a tech transfer
For global Regulatory Affairs Directors. A technology transfer can be the best decision for your manufacture – or, done wrong, it could be the worst. Our experts have identified 9 red flags to look out for before initiating a tech transfer. 1. No back-up manufacturing site Preferably, do not initiate a tech transfer unless a […]